Drug Makers’ Seemingly Whimsical Pricing Leaves Consumers Fuming And Confused

The New York Times examines how Valeant's decision to dramatically increase the cost of a drug affects spending and patients' decisions about care. Other outlets also look at the controversial issue of drug marketping, and AARP is setting up a technology fund to push innovations to help seniors.